GNH USA

Europe — EMA

Octaplex

GNH USA supplies Octaplex (Human Coagulation Factor IX), a coagulation factor for hemophilia B and acquired deficiencies. Request a quote for global supply.

Human Coagulation Factor Ix, Protein C, Human Coagulation Factor Vii, Protein S, Human Coagulation F

Request sourcing

1
Pack/s

What is Human Coagulation Factor Ix, Protein C, Human Coagulation Factor Vii, Protein S, Human Coagulation F?

Human Coagulation Factor IX, the active ingredient in Octaplex, is a coagulation factor presented as a sterile injectable solution for intravenous use. It is used to treat and prevent bleeding episodes in patients with hemophilia B and other inherited coagulation disorders. GNH USA supplies Octaplex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and transplant centres worldwide.

GNH USA supplies Octaplex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and transplant centres worldwide.

What is Human Coagulation Factor Ix, Protein C, Human Coagulation Factor Vii, Protein S, Human Coagulation F used for?

Octaplex is a plasma‑derived coagulation factor concentrate that acts on the intrinsic pathway of the clotting cascade. It is indicated for: - Hemophilia B: provides replacement therapy to control bleeding and support surgery. - Acquired factor IX deficiency: restores deficient factor levels to reduce bleeding risk. - Peri‑operative management of patients with known factor IX deficiency: maintains hemostasis during surgical procedures.

What are the side effects of Human Coagulation Factor Ix, Protein C, Human Coagulation Factor Vii, Protein S, Human Coagulation F?

Octaplex may be associated with infusion‑related reactions and immunologic responses.

Common Side Effects: - Fever or chills: mild temperature elevation during infusion. - Headache: transient headache occurring during or after administration. - Nausea: mild gastrointestinal upset. - Injection site erythema: redness at the infusion site. - Mild hypotension: slight drop in blood pressure during infusion.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Thromboembolic events: clot formation in veins or arteries. - Development of inhibitors: immune response neutralizing factor IX activity. - Hepatitis transmission: risk of viral infection from plasma‑derived products. - Severe hemolysis: rapid destruction of red blood cells.

What precautions apply to Human Coagulation Factor Ix, Protein C, Human Coagulation Factor Vii, Protein S, Human Coagulation F?

When using Octaplex, clinicians should consider several safety measures: - Monitor for inhibitors: test for factor IX antibodies before and during therapy. - Assess bleeding risk: evaluate patient history of thrombosis before administration. - Adjust dose in renal impairment: consider reduced clearance in patients with kidney disease. - Avoid in known hypersensitivity: do not administer to patients with documented allergy to plasma proteins. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Human Coagulation Factor Ix, Protein C, Human Coagulation Factor Vii, Protein S, Human Coagulation F interact with?

Octaplex can interact with other agents that affect coagulation and immune response.

Major Interactions (Avoid): - Activated protein C concentrates: may counteract the pro‑coagulant effect of factor IX. - High‑dose anticoagulants (e.g., warfarin, heparin): increase risk of bleeding when combined.

Moderate Interactions (Monitor Closely): - Immunosuppressive therapies: may alter inhibitor development risk. - Other plasma‑derived products: cumulative protein load may affect immune response. - Antifibrinolytics (e.g., tranexamic acid): may enhance clot stability, requiring dose adjustment. - Concomitant use with vaccines: monitor for altered immune response.

Frequently asked questions

What is Octaplex used for?+
Octaplex is a plasma‑derived concentrate containing human coagulation factor IX and related proteins. It is used to replace deficient clotting factors in patients with hemophilia B, acquired factor IX deficiency, or during surgery when hemostasis must be maintained in individuals with known factor IX deficiency.
How does Human Coagulation Factor IX work in Octaplex?+
The factor IX in Octaplex restores the intrinsic pathway of the clotting cascade by providing the missing protein needed for thrombin generation. Together with protein C, factor VII and protein S, it helps convert pro‑thrombin to thrombin, leading to fibrin clot formation and control of bleeding.
What is the usual dose of Octaplex?+
Dosing of Octaplex is individualized. The prescribing clinician determines the amount based on the patient’s factor IX level, severity of bleeding, body weight and the clinical situation. No fixed regimen is provided here.
Is Octaplex safe to use during pregnancy or breastfeeding?+
Octaplex is a plasma‑derived product and may be used when the benefit outweighs potential risk. Limited data exist for pregnancy and lactation, so clinicians should evaluate each case carefully and consider alternative therapies if safety cannot be assured.
How do I order Octaplex from GNH USA?+
To order Octaplex, submit an enquiry on the product page at gnh-usa.com specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and import documentation.
How does Octaplex compare with other factor IX products?+
Octaplex is a plasma‑derived factor IX concentrate that includes additional proteins such as factor VII, protein C and protein S, which may offer broader hemostatic support compared with recombinant factor IX products that contain only the single factor. Choice of product depends on clinical needs, inhibitor status and safety considerations.
What are the storage and handling requirements for Octaplex?+
Octaplex should be stored at 2‑8 °C, protected from light, and must not be frozen or shaken. Before use, allow the vial to reach room temperature if required, and inspect for any particulate matter or discoloration.
How is Octaplex administered?+
Octaplex is supplied as a sterile injectable solution for intravenous infusion. It is administered by a healthcare professional, typically through a controlled infusion set, with dosage calculated by the prescriber based on the patient’s factor IX activity level and clinical need.
What are the most serious risks associated with Octaplex?+
The most serious risks include anaphylactic reactions, development of factor IX inhibitors that neutralize therapeutic effect, thromboembolic events, and transmission of blood‑borne pathogens despite rigorous screening of donor plasma.
Who should not use Octaplex?+
Octaplex is contraindicated in individuals with known hypersensitivity to any component of the product or to plasma‑derived proteins. Patients with a history of severe allergic reactions to factor concentrates should avoid its use unless under strict medical supervision.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Human Coagulation Factor Ix, Protein C, Human Coagulation Factor Vii, Protein S, Human Coagulation F
Route
Intravenous Use
Manufacturer
Octapharma (Ip) Sprl
Origin
EU